Journal issues > Issue 5, October 2016 > Immune-mediated early-onset neonatal thrombocytopenia: a double case presentation

Immune-mediated early-onset neonatal thrombocytopenia: a double case presentation

By: K. Vanhouteghem PharmD, H. Vanhouteghem PharmD, K. De Schynkel MD, K. Van Haver MD, J. Dierick MD, A. Luyckx MD, PhD

Summary

Neonatal thrombocytopenia comprises a platelet count of less than 150×10⁹/L, with severe neonatal thrombocytopenia in case of a platelet count less than 50×10⁹/L. Severe thrombocytopenia is an uncommon finding in newborns requiring immediate diagnostic work-up with the need for urgent intervention to avoid severe bleeding complications. Neonatal thrombocytopenia can be classified by time of onset in early-onset (72h after birth) thrombocytopenia. Multiple causes may be involved. In term, otherwise healthy neonates, one important cause of early-onset thrombocytopenia is antibody-mediated platelet destruction, and this can be allo- or auto-immune-mediated. In this case presentation, we discuss two neonates with severe early-onset immune-mediated thrombocytopenia presenting simultaneously at our general hospital.

(BELG J HEMATOL 2016;7(5):188–93)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top